Report cover image

MEA Ovarian Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Nov 01, 2022
Length 140 Pages
SKU # DAABD17583291

Description

MEA Ovarian Cancer Diagnostics Market - Industry Trends and Forecast to 2030

The Middle East and Africa ovarian cancer diagnostics market, is projected to register a substantial CAGR of 6.1% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Middle East and Africa Ovarian Cancer Diagnostics Market- By Product Type (Instruments, Kits and Reagents), Procedure Type (Biopsy Test, Medical Imaging Test, Blood Markers Testing, Genetic Testing), Cancer Type (Germ Cell, Epithelial Tumor, Stromal Cell Tumor), End User (Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of Middle East and Africa ovarian cancer diagnostics market are:
• Growing ovarian cancer awareness
• Improved diagnostic processes and techniques
• Increase in number of new cases every year
• Improved imaging techniques

Market Players

The major companies which are dealing in the Middle East and Africa ovarian cancer diagnostics market are listed below:
• F. Hoffmann-la roche ltd
• Tosoh india pvt. Ltd.
• Luminex corporation
• Quest diagnostics incorporated
• Thermo fisher scientific Inc.
• Ngenebio
• Abbott
• Siemens healthcare private limited
• Myriad genetics Inc.
• Bio-rad laboratories, Inc.
• Abcam plc.
• Monobind Inc.
• Mp biomedicals
• Boster biological technology
• Genway biotech
• Lifespan biosciences, Inc

Table of Contents

140 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Middle East & Africa Ovarian Cancer Diagnostics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Growth Strategies Adopted By Key Market Players
5 Industry Insights
5.1 Conclusion
6 Regulations Of The Middle East & Africa Ovarian Cancer Diagnostics Market
7 Market Overview
7.1 Drivers
7.1.1 Growing Ovarian Cancer Awareness
7.1.2 Improved Diagnostic Processes And Techniques
7.1.3 Increase In Number Of New Cases Every Year
7.1.4 Improved Imaging Techniques
7.2 Restrains
7.2.1 High Cost Of Diagnosis
7.2.2 Adverse Effects Of The Treatment
7.3 Opportunities
7.3.1 Increasing Healthcare Expenditure For Cancer Diagnosis And Treatment
7.3.2 Government Initiatives Towards Cancer Diagnostics
7.4 Challenges
7.4.1 Strict Regulations And Standards For The Approval And Commercialization Of Cancer Diagnostic Products
7.4.2 Lack Of Skilled Professionals
8 Middle East & Africa Ovarian Cancer Diagnostics Market, By Product Type
8.1 Overview
8.2 Instruments
8.3 Kits And Reagents
9 Middle East & Africa Ovarian Cancer Diagnostics Market, By Procedure Type
9.1 Overview
9.2 Blood Markers Testing
9.3 Medical Imaging Test
9.4 Biopsy Test
9.5 Genetic Testing
10 Middle East & Africa Ovarian Cancer Diagnostics Market, By Cancer Type
10.1 Overview
10.2 Epithelial Tumor
10.3 Germ Cell
10.4 Stromal Cell Tumor
11 Middle East & Africa Ovarian Cancer Diagnostics Market, By End User
11.1 Overview
11.2 Cancer Diagnostic Centers
11.3 Hospital Laboratories
11.4 Research Institutes
11.5 Others
12 Middle East & Africa Ovarian Cancer Diagnostics Market, By Geography
12.1 Middle East And Africa
12.1.1 South Africa
12.1.2 Saudi Arabia
12.1.3 U.A.E
12.1.4 Egypt
12.1.5 Israel
12.1.6 Rest Of Middle East And Africa
13 Middle East & Africa Ovarian Cancer Diagnostics Market: Company Landscape
13.1 Company Share Analysis: Middle East & Africa
14 Swot Analysis
15 Company Profile
15.1 F. Hoffmann-la Roche Ltd
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Tosoh India Pvt. Ltd.
15.2.1 Company Snapshot
15.2.2 Company Share Analysis
15.2.3 Product Portfolio
15.2.4 Recent Development
15.3 Luminex Corporation (2022)
15.3.1 Company Snapshot
15.3.2 Company Share Analysis
15.3.3 Product Portfolio
15.3.4 Recent Development
15.4 Quest Diagnostics Incorporated (2022)
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Developments
15.5 Thermo Fisher Scientific Inc
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Development
15.6 Abbott
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Development
15.7 Abcam Plc (2022)
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 1.7.4 Recent Development
15.8 Biosupply Ltd
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Bio-radbio Laboratories
15.9.1 Company Snapshot
15.9.2 Revenue Analysis
15.9.3 Product Portfolio
15.9.4 Recent Developments
15.10 Biovision Inc.
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Development
15.11 Biogenix Inc. Pvt. Ltd.
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Boster Biological Technology
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Foundation Medicine
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Fujirebio
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Genway Biotech
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Inex Innovative Private Limited
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Lcm Genetic Srl
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Lifespan Biosciences, Inc
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Developments
15.19 Mp Biomedicals
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Monobind Inc.
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
15.21 Myriad Genetics, Inc.
15.21.1 Company Snapshot
15.21.2 Revenue Analysis
15.21.3 Product Portfolio
15.21.4 Recent Development
15.22 Ngenebio
15.22.1 Company Snapshot
15.22.2 Product Portfolio
15.22.3 Recent Developments
15.23 R&D Systems, Inc.
15.23.1 Company Snapshot
15.23.2 Product Portfolio
15.23.3 Recent Development
15.24 Siemens Medical Solutions
15.24.1 Company Snapshot
15.24.2 Revenue Analysis
15.24.3 Product Portfolio
15.24.4 Recent Development
16 Questionnaire
17 Related Reports 140
List Of Tables
Table 1 24-month Episode-of-care Costs For Early-stage And Late-stage Cancers By Payer (Usd Billion)
Table 2 Middle East & Africa Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 3 Middle East & Africa Instruments In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 4 Middle East & Africa Kits And Reagents In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 5 Middle East & Africa Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 6 Middle East & Africa Blood Markers Testing In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 7 Middle East & Africa Medical Imaging Test In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 8 Middle East & Africa Biopsy Test In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 9 Middle East & Africa Genetic Testing In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 10 Middle East & Africa Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 11 Middle East & Africa Epithelial Tumor In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 Middle East & Africa Germ Cell In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 13 Middle East & Africa Stromal Cell Tumor In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 14 Middle East & Africa Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 15 Middle East & Africa Cancer Diagnostic Centers In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 16 Middle East & Africa Hospital Laboratories In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 17 Middle East & Africa Research Institutes In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 18 Middle East & Africa Others In Ovarian Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 19 Middle East And Africa Ovarian Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 20 Middle East And Africa Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 21 Middle East And Africa Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 22 Middle East And Africa Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 23 Middle East And Africa Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 24 South Africa Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 25 South Africa Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 26 South Africa Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 27 South Africa Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 28 Saudi Arabia Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 29 Saudi Arabia Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 30 Saudi Arabia Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 31 Saudi Arabia Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 32 U.A.E Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 33 U.A.E Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 34 U.A.E Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 35 U.A.E Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 36 Egypt Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 37 Egypt Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 38 Egypt Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 39 Egypt Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 40 Israel Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 41 Israel Ovarian Cancer Diagnostics Market, By Procedure Type, 2021-2030 (Usd Million)
Table 42 Israel Ovarian Cancer Diagnostics Market, By Cancer Type, 2021-2030 (Usd Million)
Table 43 Israel Ovarian Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 44 Rest Of Middle East And Africa Ovarian Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million) 89
List Of Figures
Figure 1 Middle East & Africa Ovarian Cancer Diagnostics Market : Segmentation
Figure 2 Middle East & Africa Ovarian Cancer Diagnostics Market : Data Triangulation
Figure 3 Middle East & Africa Ovarian Cancer Diagnostics Market : Droc Analysis
Figure 4 Middle East & Africa Ovarian Cancer Diagnostics Market : Middle East & Africa Vs Regional Market Analysis
Figure 5 Middle East & Africa Ovarian Cancer Diagnostics Market : Company Research Analysis
Figure 6 Middle East & Africa Ovarian Cancer Diagnostics Market : Interview Demographics
Figure 7 Middle East & Africa Ovarian Cancer Diagnostics Market : Dbmr Market Position Grid
Figure 8 Middle East & Africa Ovarian Cancer Diagnostics Market : Market Testing Type Coverage Grid
Figure 9 Middle East & Africa Ovarian Cancer Diagnostics Market : Vendor Share Analysis
Figure 10 Middle East & Africa Ovarian Cancer Diagnostics Market : Segmentation
Figure 11 The Increase In The Awareness About Ovarian Cancer Is Expected To Drive The Middle East & Africa Ovarian Cancer Diagnostics Market In The Forecast Period Of 2022 To 2030
Figure 12 Product Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Ovarian Cancer Diagnostics Market In 2022 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenge Of The Middle East & Africa Ovarian Cancer Diagnostics Market
Figure 14 Middle East & Africa Ovarian Cancer Diagnostics Market: By Product Type, 2022
Figure 15 Middle East & Africa Ovarian Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
Figure 16 Middle East & Africa Ovarian Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
Figure 17 Middle East & Africa Ovarian Cancer Diagnostics Market: By Product Type, Lifeline Curve
Figure 18 Middle East & Africa Ovarian Cancer Diagnostics Market: By Procedure Type, 2022
Figure 19 Middle East & Africa Ovarian Cancer Diagnostics Market: By Procedure Type, 2023-2030 (Usd Million)
Figure 20 Middle East & Africa Ovarian Cancer Diagnostics Market: By Procedure Type, Cagr (2023-2030)
Figure 21 Middle East & Africa Ovarian Cancer Diagnostics Market: By Procedure Type, Lifeline Curve
Figure 22 Middle East & Africa Ovarian Cancer Diagnostics Market: By Cancer Type, 2022
Figure 23 Middle East & Africa Ovarian Cancer Diagnostics Market: By Cancer Type, 2023-2030 (Usd Million)
Figure 24 Middle East & Africa Ovarian Cancer Diagnostics Market: By Cancer Type, Cagr (2023-2030)
Figure 25 Middle East & Africa Ovarian Cancer Diagnostics Market: By Cancer Type, Lifeline Curve
Figure 26 Middle East & Africa Ovarian Cancer Diagnostics Market: By End User, 2022
Figure 27 Middle East & Africa Ovarian Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 28 Middle East & Africa Ovarian Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 29 Middle East & Africa Ovarian Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 30 Middle East And Africa Ovarian Cancer Diagnostics Market: Snapshot (2022)
Figure 31 Middle East And Africa Ovarian Cancer Diagnostics Market: By Country (2022)
Figure 32 Middle East And Africa Ovarian Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 33 Middle East And Africa Ovarian Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 34 Middle East And Africa Ovarian Cancer Diagnostics Market: By Product Type (2023-2030)
Figure 35 Middle East & Africa Ovarian Cancer Diagnostics Market: Company Share 2022 (%) 89

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us